文献速递造血干细胞移植与细胞治疗白血病

供者抑制性KIR增多与儿童急性白血病HLA相合无关供者造血干细胞移植后GVHD减少及生存改善相关

Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA-matched unrelated donor HCT in paediatric acute leukaemia.
PubMed 文献 · Br J Haematol · 2024-03-05

该回顾性分析研究儿童急性白血病患者接受HLA相合无关供者造血干细胞移植后,供者KIR-KIRL组合及最大抑制性KIR配体(IM-KIR)评分与临床结局的关系。结果显示,在抑制性KIR基因含量增高且IM-KIR=5的患者中,KIR-KIRL组合可显著预测3-4级aGVHD发生率降低,且ALL和AML患者无复发生存、GRFS和总生存均有改善。作者认为可考虑在儿童急性白血病无关供者移植中选用抑制性KIR较高的供者。

要点

  • 供者抑制性KIR基因含量增高且IM-KIR=5时,3-4级aGVHD风险显著降低。
  • ALL和AML患者中,无复发生存、GRFS和总生存均观察到改善。
  • 作者建议可考虑在儿童急性白血病无关供者移植中选用抑制性KIR较高的供者。

核心结论

  • NK细胞KIR-HLA相互作用可能与儿童急性白血病移植相关,aGVHD减少提示KIR效应可能超出NK细胞范畴。
  • 作者建议可考虑在儿童急性白血病无关供者造血干细胞移植中选用抑制性KIR较高的供者以优化临床结局。

研究设计与样本

  • 回顾性分析儿童急性白血病患者,确定KIR-KIRL组合及最大抑制性KIR配体(IM-KIR)评分。
  • 采用一系列描绘临床事件和终点的图表方法检查临床结局。

主要发现

  • 图表方法显示,在特定临床终点发生中显著的预后变量对相关下游事件仍保持显著。
  • 在抑制性KIR基因含量增高且IM-KIR=5的患者中,KIR-KIRL组合可显著预测3-4级aGVHD可能性降低。
  • ALL和AML患者中,无复发生存、GRFS和总生存等相关结局均观察到改善。

临床怎么用

  • 作者认为,在儿童急性白血病无关供者造血干细胞移植中,可考虑选用抑制性KIR较高的供者以优化临床结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Killer immunoglobulin-like receptor (KIR) and KIR-ligand (KIRL) interactions play an important role in natural killer cell-mediated effects after haematopoietic stem cell transplantation (HCT). Previous work has shown that accounting for known KIR-KIRL interactions may identify donors with optimal NK cell-mediated alloreactivity in the adult transplant setting. Paediatric acute leukaemia patients were retrospectively analysed, and KIR-KIRL combinations and maximal inhibitory KIR ligand (IM-KIR) scores were determined. Clinical outcomes were examined using a series of graphs depicting clinical events and endpoints. The graph methodology demonstrated that prognostic variables significant in the occurrence of specific clinical endpoints remained significant for relevant downstream events. KIR-KIRL combinations were significantly predictive for reduced grade 3-4 aGVHD likelihood, in patients transplanted with increased inhibitory KIR gene content and IM-KIR = 5 scores. Improvements were also observed in associated outcomes for both ALL and AML patients, including relapse-free survival, GRFS and overall survival. This study demonstrates that NK cell KIR HLA interactions may be relevant to the paediatric acute leukaemia transplant setting. Reduction in aGVHD suggests KIR effects may extend beyond NK cells. Moving forward clinical trials utilizing donors with a higher iKIR should be considered for URD HCT in paediatric recipients with acute leukaemia to optimize clinical outcomes.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Krieger E, Qayyum R, Toor A, et al. Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA-matched unrelated donor HCT in paediatric acute leukaemia. Br J Haematol. 2024. PMID: 38442905. doi:10.1111/bjh.19356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。